Publicaciones en las que colabora con Francisco Ros Bernal (16)

2014

  1. Glutamatergic receptors in parkinson's disease

    Handbook of Neurotoxicity (Springer New York), pp. 1311-1340

  2. Neuroinflammation and parkinson's disease

    Handbook of Neurotoxicity (Springer New York), pp. 885-912

2013

  1. Effects of pharmacological agents, sleep deprivation, Hypoxia and transcranial magnetic stimulation on electroencephalographic rhythms in rodents: Towards translational challenge models for drug discovery in Alzheimer's disease

    Clinical Neurophysiology, Vol. 124, Núm. 3, pp. 437-451

  2. Evidence of oligodendrogliosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism

    Neuropathology and Applied Neurobiology, Vol. 39, Núm. 2, pp. 132-143

  3. Persistent phagocytic characteristics of microglia in the substantia nigra of long-term parkinsonian macaques

    Journal of Neuroimmunology, Vol. 261, Núm. 1-2, pp. 60-66

2012

  1. 7-Nitroindazole down-regulates dopamine/DARPP-32 signaling in neostriatal neurons in a rat model of Parkinson's disease

    Neuropharmacology, Vol. 63, Núm. 7, pp. 1258-1267

  2. CCL2-Expressing astrocytes mediate the extravasation of T lymphocytes in the brain. Evidence from patients with glioma and experimental models in vivo

    PLoS ONE, Vol. 7, Núm. 2

  3. Dopamine modulation affects the performance of parkinsonian patients in a precision motor task measured by an antropomorphic device

    Human Movement Science, Vol. 31, Núm. 3, pp. 730-742

  4. Erratum: IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's diseas (Cell Death and Disease (2011) 2 (e142) 10.1038/cddis.2011.17)

    Cell Death and Disease

  5. Neuroinflammation in Parkinson's disease: A role for matrix metalloproteinases?

    Neuroinflammation: Pathogenesis, Mechanisms and Management (Nova Science Publishers, Inc.), pp. 65-88

  6. Nigral degeneration correlates with persistent activation of cerebellar Purkinje cells in MPTP-treated monkeys

    Histology and Histopathology, Vol. 27, Núm. 1, pp. 89-94

  7. ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo

    Scientific Reports, Vol. 2

2011

  1. IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease

    Cell Death and Disease, Vol. 2, Núm. 4

  2. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, Núm. 16, pp. 6632-6637

2009

  1. MPTP administration increases plasma levels of acute phase proteins in non-human primates (Macaca fascicularis)

    Neuroscience Letters, Vol. 463, Núm. 1, pp. 37-39

  2. No Lewy pathology in monkeys with over 10 years of severe MPTP parkinsonism

    Movement Disorders, Vol. 24, Núm. 10, pp. 1519-1523